Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon ( significant proportion of infected indi...)

Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon

significant proportion of infected individuals, leading to cirrhosis, primary liver cancer, and even death.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. The Company's primary focus is rapid progress toward the commercialization of its two lead compounds, Albuferon(R) for hepatitis C, and LymphoStat-B(R) for lupus. Phase 3 clinical trials of both compounds are now underway.

In June 2006, HGS announced that the U.S. Government exercised its option under an existing contract to purchase 20,000 doses of ABthrax(TM) for the treatment of anthrax disease. Other HGS drugs in clinical development include two TRAIL receptor antibodies for the treatment of hematopoietic and solid malignancies, in addition to an antibody to the CCR5 receptor for the treatment of HIV/AIDS.

For more information about HGS, please visit the Company's web site at www.hgsi.com. For more information about Albuferon, please visit http://www.hgsi.com/products/albuferon.html. Health professionals or patients interested in Albuferon clinical trials or other studies involving HGS products may inquire via the Contact Us section of the Company's web site, www.hgsi.com/products/request.html, or by calling us at (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and
'"/>

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
6. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
9. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
10. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model

Post Your Comments:

(Date:3/18/2010)... SOUTH SAN FRANCISCO, Calif. , March 18 ... company focused on innovative oncology therapies, today announced that the ... reissue the composition of matter patent for picoplatin as RE41209, ... . The reissue was applied for May 8, 2009 ...

(Date:3/18/2010)... WASHINGTON , March 18 ... Pfizer, was elected board chairman of the Pharmaceutical Research ... association,s annual meeting. Also elected were sanofi-aventis Chief Executive ... PhRMA Board of Directors, and John C. Lechleiter ...

(Date:3/18/2010)... The U.S. Food and Drug Administration today approved Carbaglu (carglumic acid) Tablets to treat a condition that results in too much ammonia in the blood. , ... , , ... ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , ...

Breaking Medicine Technology:U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 2 U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 3 U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 4 U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 5 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7 Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 2 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 3 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 4 FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 5 This Holiday Season Give Your Children the Gift that Saves Lives 3A Safer Sex 63197 1 This Holiday Season Give Your Children the Gift that Saves Lives 3A Safer Sex 63197 2 Newly identified enzymes help plants sense elevated CO2 and could lead to water wise crops 11131 1 Newly identified enzymes help plants sense elevated CO2 and could lead to water wise crops 11131 2 Newly identified enzymes help plants sense elevated CO2 and could lead to water wise crops 11131 3 Mobility Consignment Announces New Tools for Handicapped Persons Now Available to Assist with Finding Handicapped Vehicles 63193 1 Mobility Consignment Announces New Tools for Handicapped Persons Now Available to Assist with Finding Handicapped Vehicles 63193 2

[0] U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter [0] Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts [0] FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels

... 25 "Weight management is serious,business. National health ... are over weight, and for many obesity is ... a health hazard. Then why leave it to ... the latest ,food,system,?" Dr. Frederic J. Vagnini, ...

... and Innovation, AUDUBON, Pa., Aug. 23 Globus ... world, today announced,the closing of a $110 million series ... was joined by AIG SunAmerica and other large,institutional private ... placement agent. The Series E financing will be ...

Other Medicine Technology:The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management 2 Globus Medical Raises $110 Million in Series E Financing Round 2

The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management Globus Medical Raises $110 Million in Series E Financing Round

(Date:3/18/2010)... bloodstream infection risk reduction strategies in PA health facilities are questioned , ... , , ... ... ...

(Date:3/18/2010)... , ... , ... ... WASHINGTON , March 18 S.T.O.P. - Safe Tables Our Priority and victims of foodborne illness called upon the United ...

(Date:3/18/2010)... of Public Health will receive nearly $15 million from ... and modernization of laboratory space at its main facility ... grant was awarded by the National Center for Research ... renovation includes updating labs and new infrastructure in the ...

(Date:3/18/2010)... pregnancy, researcher says , , THURSDAY, March 18 (HealthDay News) -- ... will develop asthma, a new study finds. , The role ... suggest that prenatal stress can influence the infant,s immune system ... that asthma is most prevalent in inner cities, where minorities ...

(Date:3/18/2010)... China , March 18 /PRNewswire-Asia/ -- Earlier this month, http://www.glassesshop.com ("GS"), the world,s leading online eyewear selling,website, launched a themed event before the "Save ... ... , , ... ...

Breaking Medicine News(10 mins):Health News:Studies Show Significant Increases of C. Difficile Infections (CDI) 2 Health News:Studies Show Significant Increases of C. Difficile Infections (CDI) 3 Health News:Studies Show Significant Increases of C. Difficile Infections (CDI) 4 Health News:Studies Show Significant Increases of C. Difficile Infections (CDI) 5 Health News:Studies Show Significant Increases of C. Difficile Infections (CDI) 6 Health News:Studies Show Significant Increases of C. Difficile Infections (CDI) 7 Health News:Victims of Contaminated Meat Call on USDA to Address Deadly Pathogens 2 Health News:Victims of Contaminated Meat Call on USDA to Address Deadly Pathogens 3 Health News:Prenatal Stress May Boost Baby's Asthma Risk 2 Health News:Prenatal Stress May Boost Baby's Asthma Risk 3 Health News:Glassesshop.com Has Launched 'Save Your Vision Week' Themed Event 2

[0] Studies Show Significant Increases of C. Difficile Infections (CDI)[0] Victims of Contaminated Meat Call on USDA to Address Deadly Pathogens [0] Bloomberg School of Public Health awarded $15 million for laboratory renovation and modernization [0] Prenatal Stress May Boost Baby's Asthma Risk [0] Glassesshop.com Has Launched 'Save Your Vision Week' Themed Event

... Reflecting Growth of 27-29 Percent over ... 2007 First-Quarter Year-Over-Year Highlights (adjusted for January ... two-for-one stock split): - ... $0.55 from $0.52, excluding $0.05 in amortization of intangible ...

... benefit: increasing the amount of insulin produced by ... insulin resistance, the first step toward type 2 ... known to reduce blood glucose in diabetic patients. ... of Clinical Endocrinology & Metabolism reveals a similar ...

... Serious Financial Burden Caused By Medical,Bills; 7 Percent Say ... Spouse Could Get Health Benefits, MENLO PARK, Calif., ... personal economic problems, and their,struggles to deal with those ... health care, a new Kaiser Family Foundation,poll finds., ...

... on Wednesday, April 30 at 2 p.m. Eastern -, ... VRML ), a molecular diagnostics company, will host a ... peripheral,artery disease (PAD) and to provide information about the ... The,teleconference will take place on Wednesday, April 30 at ...

... return to work, analysis finds , , MONDAY, April 28 ... surgically implanting an artificial vertebrae onto one,s spine may ... but it saves the patient almost $6,000 within two ... cost savings is primarily from the patient,s ability to ...

... Inscent, Inc. has received a,Small Business ... Science,Foundation (NSF) to continue the testing and ... Attenu high throughput assay system. The,pioneering research ... highly,efficient processes that allow the rapid development ...

Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates Aspirin-like compounds increase insulin secretion in otherwise healthy obese people Americans Rank Health Care Near the Top of Their Economic Woes, New Poll Finds Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program Artificial Cervical Disc Surgery Cheaper Than Fusion Inscent, Inc. Receives Federal Grant to Develop Honeybee Repellents

(1-15 LPM), 50 psi, 1/ 8" NPT female back inlet...

Pediatric (1/10-1 LPM), 50 psi back inlet, wall mounted, 1/8" NPT female....

... flowmeters., ,Options: , For ... to model number. Example: FMC107S. ... suffix C to model number. ... Flowmeters with Power Take-Off, add ...

Value-Line oxygen flowmeters. ,Options: , For security chain, add suffix S to model number. Example: FMQ107S. , For Canadian Color-Code, add suffix FMQ104C. , For Double Flowmeters with Power Take-Of...

Medicine Products:

Oxygen Flowmeter (Cylindrical Style)Pediatric Oxygen Flowmeter (Block Style)Click Style Oxygen Power Take Off Flowmeters Value-Line Oxygen Flowmeters

( significant proportion of infected indi...)Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon,Health